Prevalence and presentation of hepatitis C related chronic liver disease in southern India
- PMID: 7783272
Prevalence and presentation of hepatitis C related chronic liver disease in southern India
Abstract
To determine the importance of hepatitis C virus (HCV) infection in the aetiology of chronic liver disease in southern India, the prevalence of HCV antibodies and HBV markers was estimated in 100 patients with chronic liver disease and in 56 patients with a variety of other gastrointestinal and liver diseases who served as controls. HCV antibody was measured by a second-generation ELISA. HBsAg, anti-HBc, anti-HBs and anti-D were also estimated. HCV antibodies were detected in 26/100 patients with chronic liver disease compared to 0/56 controls. HBV markers were present in 72 of 100 patients with chronic liver disease compared to 21/56 (37.5%) controls. Anti-D was noted in 4/100 patients with chronic liver disease and in none of the controls. Many patients had serological evidence of both B and C infection; 73% of those with anti-HCV also tested positive for HBV markers. HCV related disease presented at a median age of 60 years compared to HBV related disease which presented at a median age of 40. There was no significant difference between HCV and HBV positive patients in symptomatology, but encephalopathy was uncommon and cirrhosis the usual finding at histology in HCV positive individuals, while chronic active hepatitis was found in 30% of biopsied HBV related disease. HCV is a significant cause of chronic liver disease in this geographic region, although HBV infection continues to account for the largest proportion of cases.
Similar articles
-
Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.Trop Gastroenterol. 2007 Jan-Mar;28(1):19-23. Trop Gastroenterol. 2007. PMID: 17896605
-
Prevalence and outcomes of HBV and anti-HCV seropositive patients with chronic liver disease and hepatocellular carcinoma.Southeast Asian J Trop Med Public Health. 1992 Mar;23(1):6-11. Southeast Asian J Trop Med Public Health. 1992. PMID: 1326124
-
[Prevalence of HBV surface antigens, anti-HBD and anti-HCV antibodies in patients with virus-related chronic liver disease].Mikrobiyol Bul. 1993 Oct;27(4):308-13. Mikrobiyol Bul. 1993. PMID: 7505386 Turkish.
-
[Incidence of hepatitis B, C and D infection in chronic liver diseases].Orv Hetil. 1992 Sep 27;133(39):2475-80. Orv Hetil. 1992. PMID: 1408083 Review. Hungarian.
-
Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.Princess Takamatsu Symp. 1995;25:27-32. Princess Takamatsu Symp. 1995. PMID: 8875606 Review.
Cited by
-
Clinicopathological features and genotype distribution in patients with hepatitis C virus chronic liver disease.Indian J Gastroenterol. 2009 Mar-Apr;28(2):53-8. doi: 10.1007/s12664-009-0018-z. Epub 2009 Aug 21. Indian J Gastroenterol. 2009. PMID: 19696989
-
Hepatitis C in India.J Biosci. 2008 Nov;33(4):465-73. doi: 10.1007/s12038-008-0065-0. J Biosci. 2008. PMID: 19208972 Review.
-
Clinical Profile and Response to Treatment with Pegylated Interferon α 2b and Ribavirin in Chronic Hepatitis C-A Reappraisal from a Tertiary Care Center in Northern India.J Clin Exp Hepatol. 2014 Jun;4(2):101-5. doi: 10.1016/j.jceh.2014.05.012. Epub 2014 Jun 18. J Clin Exp Hepatol. 2014. PMID: 25755547 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical